You are on page 1of 9

SHIELD ULCER

1
SHIELD ULCER
Two hypotheses for pathogenesis of shield ulcer:

Mechanical Toxin
hypothesis hypothesis

Corneal
damage

2
*Reddy, Jagadesh C., et al. "Management, clinical outcomes, and complications of
shield ulcers in vernal keratoconjunctivitis." American journal of ophthalmology 155.3
(2013): 550-559.
MECHANICAL HYPOTHESIS

Corneal surface is
abraded by the giant
papillae on the upper
tarasal conjunctiva.

 Explain the predilection of


these ulcer to appear in superior
part of the cornea

N = 193 eyes

Reddy, Jagadesh C., et al. "Management, clinical outcomes, and complications 3of
shield ulcers in vernal keratoconjunctivitis." American journal of ophthalmology 155.3
(2013): 550-559.
TOXIN HYPOTHESIS

A dense plaque is
formed over shield
ulcer by the
deposition of toxic
eosinophic granule
major protein 
secreted by
activated eosinophils
 cytotoxic and
delays re-
epithelization

Takamura, Etsuko, et al. "Allergic Conjunctival Diseases." Allergology International 60 (2011): 191-


203.
The main aim of managing shield ulcers

• Preventing the release of toxic inflammation


mediators  Promote rapid re-epithelialization
1 • By control VKC

• Prevent direct mechanical trauma resulting from


the large cobblestone papillae
• By control VKC, AMT - amniotic membrane
2 transplantation

• Provide a healthy environment for corneal


epithelium
• By debridement to remove the toxic inflammation
3 material, ATM

Reddy, Jagadesh C., et al. "Management, clinical outcomes, and complications 5of
shield ulcers in vernal keratoconjunctivitis." American journal of ophthalmology 155.3
(2013): 550-559.
Roles of amniotic membrane transplanation in
management of shield ulcer
 Act as physical barrier:
 Preventing direct mechanical damage of the cornea by giant papillae.
 Preventing direct access of the toxins from activated eosinophils to the
cornea and deposition of MBP present in abundance in tear film.
 Helping epithelial migration and anchoring
 Reducing corneal scaring
 By suppressing transforming growth factor ß signaling, proliferation
and myofibroblast differentiation of normal corneal fibroblast.

Sridhar, M. S., et al. "Amniotic membrane transplantation in the management of 6

shield ulcers of vernal keratoconjunctivitis." Ophthalmology 108.7 (2001): 1218-1222.


Reddy, Jagadesh C., et al. "Management, clinical outcomes, and
complications of shield ulcers in vernal keratoconjunctivitis." American
journal of ophthalmology 155.3 (2013): 550-559.

Treatment options depend on grade of shield ulcer:


Only medical (1)Medical (1) Medical
treatment treatment combined treatment
1) Sodium cromoglycate with combined with
2% or 4% - tid (2) Debridement. (2) AMT:
2) Topical
corticosteroid:
 When NO signs of re-
Prednisolone acetate (At slit lamp or in epithelialization wthin
1% or fluorometholone operating room using 2 weeks
0.25% (glaucoma pts) no.15 blade or the tip of  After debirdement or
– 4-8 times daily. 26 gauge needle) suferfiacial keratoectomy.
3) Antibiotic eye drops x
4 times daily Superficial Signs of re-
4) Lubricating keratoectomy : when epithelialization:
only debridement failed decrease in size of
to remove inflammation epithelial defect of at
debris or plaque least 1mm from the
baseline within7 2 weeks.
Reddy, Jagadesh C., et al. "Management, clinical outcomes, and
complications of shield ulcers in vernal keratoconjunctivitis." American
journal of ophthalmology 155.3 (2013): 550-559.

N = 193 Grade 1 Grade 2 Grade 3


71 (37%) 79 (41%) 43 (22%)
Methods of treatment
Only medical treatment 71 41 6
Debridement 0 21 10
AMT 0 17 27
Re-epithelialized eye
Only medical treatment 67 (94%) 36 (88%) 1 (17%)
Debridement NA 20 (95%) 10 (100%)
AMT NA 17 (100%) 27 (100%)
Mean re-epithelialization time 20 days

8
Reddy, Jagadesh C., et al. "Management, clinical outcomes, and
complications of shield ulcers in vernal keratoconjunctivitis." American
journal of ophthalmology 155.3 (2013): 550-559.

Features Conclusion
Grade Shield ulcer with a Respond well to medical
1 clear base therapy alone
Grade Ulcers with visible May required additional
2 inflammatory diberdement or AMT
debris at the base
Grade Shield ulcers with Largely refractory to medical
3 elevated plaques therapy
Required debridement and
AMT for rapid re
epithelialization

You might also like